CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Rodman & Renshaw Annual Global Investment Conference on Tuesday, September 13, 2011 at 1:35 p.m. ET at the Waldorf=Astoria New York Hotel.
